WEREWOLF THERAPEUTICS INC (HOWL)
US95075A1079 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -41.59M | -37.37M | -53.81M | -49.98M | -15.04M | |||
| Depreciation Amortization | 1.80M | 1.76M | 1.10M | 220.00K | 150.00K | |||
| Change In Working Capital | -8.39M | -5.89M | 2.54M | 2.28M | 2.31M | |||
| Interest Paid | N/A | 2.56M | N/A | N/A | N/A | |||
| Other non cash items | 10.16M | 8.89M | 9.57M | 4.61M | -6.04M | |||
| OPERATING CASH FLOW | -38.01M | -32.61M | -40.60M | -42.88M | -18.62M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -710.00K | -769.00K | -3.61M | -500.00K | -560.00K | |||
| INVESTING CASH FLOW | -710.00K | -769.00K | -3.61M | -500.00K | -560.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 40.00M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 29.98M | 18.43M | 16.45M | 111.81M | 94.20M | |||
| Other Financing Activity | N/A | 0.00 | -540.00K | -2.38M | -340.00K | |||
| FINANCING CASH FLOW | 30.07M | 58.43M | 15.91M | 109.43M | 93.86M | |||
| CHANGE IN CASH | -8.65M | 25.05M | -28.30M | 66.05M | 74.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.01M | -32.61M | -40.60M | -42.88M | -18.62M | |||
| Capital Expenditure | -710.00K | -769.00K | -3.61M | -500.00K | -560.00K | |||
| FREE CASH FLOW | -38.72M | -33.38M | -44.21M | -43.38M | -19.18M | |||
All data in USD